New chemotherapeutic agents--bleomycin and adriamycin.
D001761:Bleomycin / Q000009:adverse effects / Q000627:therapeutic use*; D004317:Doxorubicin / Q000009:adverse effects / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008297:Male; D009369:Neoplasms / Q000188:drug therapy*
D001761:Bleomycin; D004317:Doxorubicin